The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marleau, S.
Right arrow Articles by Borgeat, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marleau, S.
Right arrow Articles by Borgeat, P.
The Journal of Immunology, 1999, 163: 3449-3458.
Copyright © 1999 by The American Association of Immunologists

Role of 5-Lipoxygenase Products in the Local Accumulation of Neutrophils in Dermal Inflammation in the Rabbit1

Sylvie Marleau2,3,*, Bernard Fruteau de Laclos{dagger}, Ana B. Sanchez*, Patrice E. Poubelle* and Pierre Borgeat*

* Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du Centre Hospitalier Universitaire de Québec (Pavillon Centre Hospitalier de l’Université Laval) et Faculté de Médecine, Université Laval, Ste-Foy, Québec, Canada; and {dagger} Hôpital du Saint-Sacrement, Québec, Canada

Studies were undertaken to define the role of 5-lipoxygenase (5-LO) products and, in particular, of leukotriene (LT) B4 in the polymorphonuclear leukocyte (PMN) emigration process using a rabbit model of dermal inflammation. Our results show that i.v. administration to rabbits of MK-0591, a compound that inhibits LT biosynthesis in blood and tissues when administered in vivo, significantly reduced 51Cr-labeled PMN accumulation in response to intradermally injected chemotactic agonists, including IL-8, FMLP, C5a, and LTB4 itself. In addition, pretreatment of the labeled PMN with MK-0591 ex vivo before their injection in recipient animals was equally effective in reducing 51Cr-labeled PMN emigration to dermal inflammatory sites. These results support a role for de novo synthesis of 5-LO metabolites by PMN for their chemotactic response to inflammatory mediators. Other studies demonstrated that elevated intravascular concentration of LTB4 interferes with PMN extravasation inasmuch as a continuous i.v. infusion of LTB4, in the range of 5–300 ng/min/kg, dose-dependently inhibited extravascular PMN accumulation to acute inflammatory skin sites elicited by the chemoattractants LTB4, FMLP, C5a, and IL-8 and by TNF-{alpha}, IL-1ß, and LPS; such phenomena may constitute a natural protective mechanism from massive tissue invasion by activated PMN in specific pathologic conditions such as ischemia (and reperfusion). These studies demonstrate additional functions of 5-LO products in the regulation of PMN trafficking, distinct from the well-characterized chemotactic activity of LTB4 present in the extravascular compartment.




This article has been cited by other articles:


Home page
J. Nutr.Home page
M. A. V. Landgraf, L. L. Martinez, V. M. F. Rastelli, M. d. C. P. Franco, M. Soto-Suazo, R. d. C. A. Tostes, M. H. C. Carvalho, D. Nigro, and Z. B. Fortes
Intrauterine Undernutrition in Rats Interferes with Leukocyte Migration, Decreasing Adhesion Molecule Expression in Leukocytes and Endothelial Cells
J. Nutr., June 1, 2005; 135(6): 1480 - 1485.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. T. Lappegard, J. Riesenfeld, O.-L. Brekke, G. Bergseth, J. D. Lambris, and T. E. Mollnes
Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface-Induced Eicosanoid Production
Ann. Thorac. Surg., March 1, 2005; 79(3): 917 - 923.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. J. Coffey, G. E. Jarvis, J. M. Gibbins, B. Coles, N. E. Barrett, O. R.E. Wylie, and V. B. O'Donnell
Platelet 12-Lipoxygenase Activation via Glycoprotein VI: Involvement of Multiple Signaling Pathways in Agonist Control of H(P)ETE Synthesis
Circ. Res., June 25, 2004; 94(12): 1598 - 1605.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Tarlowe, K. B. Kannan, K. Itagaki, J. M. Adams, D. H. Livingston, and C. J. Hauser
Inflammatory Chemoreceptor Cross-Talk Suppresses Leukotriene B4 Receptor 1-Mediated Neutrophil Calcium Mobilization and Chemotaxis After Trauma
J. Immunol., August 15, 2003; 171(4): 2066 - 2073.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
X. Chen, N. Li, S. Wang, N. Wu, J. Hong, X. Jiao, M. J. Krasna, D. G. Beer, and C. S. Yang
Leukotriene A4 Hydrolase in Rat and Human Esophageal Adenocarcinomas and Inhibitory Effects of Bestatin
J Natl Cancer Inst, July 16, 2003; 95(14): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Grenier, N. Flamand, J. Pelletier, P. H. Naccache, P. Borgeat, and S. G. Bourgoin
Arachidonic acid activates phospholipase D in human neutrophils; essential role of endogenous leukotriene B4 and inhibition by adenosine A2A receptor engagement
J. Leukoc. Biol., April 1, 2003; 73(4): 530 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Klein, A. Talvani, P. M. R. Silva, M. A. Martins, T. N. C. Wells, A. Proudfoot, N. W. Luckacs, and M. M. Teixeira
Stem Cell Factor-Induced Leukotriene B4 Production Cooperates with Eotaxin to Mediate the Recruitment of Eosinophils During Allergic Pleurisy in Mice
J. Immunol., July 1, 2001; 167(1): 524 - 531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Gronert, T. Martinsson-Niskanen, S. Ravasi, N. Chiang, and C. N. Serhan
Selectivity of Recombinant Human Leukotriene D4, Leukotriene B4, and Lipoxin A4 Receptors with Aspirin-Triggered 15-epi-LXA4 and Regulation of Vascular and Inflammatory Responses
Am. J. Pathol., January 1, 2001; 158(1): 3 - 9.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.